News
One day after the European Medicines Agency requested that three clinical trials of Elevidys be placed on hold after the ...
Substandard and fake medicines remain a major threat in Africa, risking lives and fuelling drug resistance. A unified ...
A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 - but only if between two and ...
Needham analyst Gil Blum lowered the firm’s price target on Sarepta (SRPT) to $183 from $202 and keeps a Buy rating on the ...
6d
Pharmaceutical Technology on MSNDaiichi and AstraZeneca’s Enhertu gains EC approval for breast cancersThe EC has approved Daiichi Sankyo and AstraZeneca’s Enhertu for use as a single agent to treat adults with certain breast ...
Weight loss drugs such as semaglutide, found in Ozempic and Wegovy, are tied to a 40% reduced risk of an Alzheimer's disease diagnosis. On Wednesday, a study in Nature suggested that a vaccine for ...
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its ...
Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.
1dOpinion
The Jordan Times on MSNHikma signs licensing agreement to bring innovative oncology treatment to MENAAMMAN — Hikma Pharmaceuticals PLC (Hikma) on Wednesday announced an exclusive licensing agreement with pharmaand GmbH (pharma ...
New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...
Telangana: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results